🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07683195
Enrolling by invitation Observational

Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction

NCT07683195 · tracked via the Priya Life Science China tracker
Sponsor
Liu Yang
Phase
Observational
Started
2020-01-01
Last updated
2026-07-07

Condition(s) studied

Gastric Cancer

Study summary

This study aims to develop a model for predicting postoperative recurrence in patients with LAGC using artificial intelligence (AI) technology based on preoperative computed tomography (CT) images

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. pathology diagnosis of LAGC (pT2NxM0-pT4NxM0); 2. radical gastrectomy with D2 lymph node dissection (\>15 lymph nodes); 3. available clinicopathological data; 4. patients underwent contrast-enhanced abdominal CT scans within 4 weeks before surgery. Exclusion Criteria: 1. preoperative treatment for LAGC (radiotherapy, chemotherapy, or systemic therapy); 2. previous malignancies; 3. unsatisfactory gastric distention or inability to identify the primary tumor; 4. image artifacts.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
QianfoshanH Jinan Shandong

More Liu Yang trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07683195 on ClinicalTrials.gov ↗ ← All trials in China